Home AtriCure

AtriCure

4/23/19: First Patient Enrollment in the Restart DEEP IDE Trial Reports AtriCure

The DEEP IDE trial is intended to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients with persistent or long-standing persistent atrial fibrillation

cryoICE cryoSPHERE Probe Launched by AtriCure

2/12/19: The launch of the cryoSPHERE probe demonstrates AtriCure’s commitment to continued innovation in Cryo Nerve Block Therapy.

AtriCure Announces Completion of Patient Enrollment in the CONVERGE IDE Clinical Trial

8/28/18: Landmark study is the first prospective, randomized study comparing the Convergent approach to endocardial catheter ablation in persistent and long-standing persistent atrial fibrillation patients.

AtriCure’s AtriClip System Surpasses 100,000 Units Sold Worldwide

  Mike Carrel, President and Chief Executive Officer of AtriCure notes, “The AtriClip franchise is one of the...